日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fine-tuned protein language model identifies antigen-specific B cell receptors from immune repertoires

精细调整的蛋白质语言模型可从免疫库中识别抗原特异性B细胞受体

Paco, Karen; Mendivil, Mariana Paco; Zhang, Zihao; Zebardast, Sanaz; Davila, Christian; Mooney, Ryan M; Olatoyinbo, Peace; Yang, Tristan; Bassi, Sebastian; Gonzalez, Virginia; Chen, Eva; Ashraf, Faisal Bin; Roman, Isabel Condori; Felix, Jonathan R; Alam, Rashid M; Lay, Jordan A; Johal, Malkiat S; Le Roch, Karine G; Tolstorukov, Ilya; Hernandez, Jeniffer B; da Silva, Fernando L Barroso; Lonardi, Stefano; Sazinsky, Matthew H; Ray, Animesh

Streamlined Multi-Attribute Assessment of an Array of Clinical-Stage Antibodies: Relationship Between Degradation and Stability

一系列临床阶段抗体的简化多属性评估:降解与稳定性之间的关系

Pastrana, Belinda; Culyba, Elizabeth; Nieves, Sherly; Sazinsky, Stephen L; Canto, Eduardo I; Noda, Isao

Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types

靶向人或小鼠VSIG4的抗体可使肿瘤相关巨噬细胞重新极化,从而在多种癌症类型中诱导强效且特异的临床抗肿瘤反应。

Stephen Sazinsky ,Mohammad Zafari ,Boris Klebanov ,Jessica Ritter ,Phuong A Nguyen ,Ryan T Phennicie ,Joe Wahle ,Kevin J Kauffman ,Maja Razlog ,Denise Manfra ,Igor Feldman ,Tatiana Novobrantseva

Preclinical Efficacy of VTX-0811: A Humanized First-in-Class PSGL-1 mAb Targeting TAMs to Suppress Tumor Growth

VTX-0811 的临床前疗效:一种针对 TAM 抑制肿瘤生长的人源化首创 PSGL-1 mAb

Tatiana Novobrantseva, Denise Manfra, Jessica Ritter, Maja Razlog, Brian O'Nuallain, Mohammad Zafari, Dominika Nowakowska, Sara Basinski, Ryan T Phennicie, Phuong A Nguyen, Michael A Brehm, Stephen Sazinsky, Igor Feldman

PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages

PSGL-1阻断诱导人肿瘤相关巨噬细胞的经典激活

Kevin Kauffman # ,Denise Manfra # ,Dominika Nowakowska # ,Mohammad Zafari ,Phuong A Nguyen ,Ryan Phennicie ,Elisabeth H Vollmann ,Brian O'Nuallain ,Sara Basinski ,Veronica Komoroski ,Kate Rooney ,Elizabeth K Culyba ,Joseph Wahle ,Carola Ries ,Michael Brehm ,Steve Sazinsky ,Igor Feldman ,Tatiana I Novobrantseva

Structural and Kinetic Characterization of Hyperthermophilic NADH-Dependent Persulfide Reductase from Archaeoglobus fulgidus

嗜热古生菌(Archaeoglobus fulgidus)NADH依赖性过硫化物还原酶的结构和动力学表征

Shabdar, Sherwin; Anaclet, Bukuru; Castineiras, Ana Garcia; Desir, Neyissa; Choe, Nicholas; Crane, Edward J 3rd; Sazinsky, Matthew H

Publisher Correction: CryoEM structure of the type IVa pilus secretin required for natural competence in Vibrio cholera

出版商更正:霍乱弧菌天然感受态所需的IVa型菌毛分泌素的冷冻电镜结构

Weaver, Sara J; Ortega, Davi R; Sazinsky, Matthew H; Dalia, Triana N; Dalia, Ankur B; Jensen, Grant J

CryoEM structure of the type IVa pilus secretin required for natural competence in Vibrio cholerae

霍乱弧菌自然能力所需的 IVa 型菌毛分泌素的冷冻电镜结构

Sara J Weaver, Davi R Ortega, Matthew H Sazinsky, Triana N Dalia, Ankur B Dalia, Grant J Jensen

ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models

JTX-2011(vopratelimab)对ICOS的激动作用需要初始T细胞启动和Fc交联才能在临床前模型中实现最佳的T细胞活化和抗肿瘤免疫。

Amanda Hanson ,Kutlu Elpek ,Ellen Duong ,Lindsey Shallberg ,Martin Fan ,Calvin Johnson ,Matthew Wallace ,George R Mabry ,Stephen Sazinsky ,Lauren Pepper ,Chengyi J Shu ,Sriram Sathyanarayanan ,Sarah Zuerndorfer ,Tyler Simpson ,Monica Gostissa ,Michael Briskin ,Deborah Law ,Jennifer Michaelson ,Christopher J Harvey

A broader active site in Pyrococcus horikoshii CoA disulfide reductase accommodates larger substrates and reveals evidence of subunit asymmetry

霍氏热球菌CoA二硫键还原酶中更宽的活性位点可以容纳更大的底物,并揭示了亚基不对称的证据。

Sea, Kevin; Lee, Jerry; To, Daniel; Chen, Berniece; Sazinsky, Matthew H; Crane, Edward J 3rd